Martin J. Abrahamson, MD, is associate professor of medicine at Harvard Medical School, director of the Division of Continuing Medical Education in the Department of Medicine, and an active faculty member of the Endocrine Division, Department of Medicine at Beth Israel Deaconess Medical Center in Boston, Massachusetts. He received his medical degree from University of Cape Town in South Africa and completed his internship, residency, and clinical fellowship in internal medicine and endocrinology at Groote Schuur Hospital in Cape Town, where he was a research fellow before joining the faculty of medicine at the University of Cape Town and Groote Schuur Hospital.
Dr. Abrahamson was joint head of the Endocrine Unit in Cape Town before taking up a faculty appointment at Harvard Medical School and Beth Israel Hospital in 1992. He joined the faculty at Joslin Diabetes Center in 1998, where he held positions as Chief of Adult Diabetes, Chief Medical Officer, and Senior Vice President for Medical Affairs until 2015. While at Joslin Diabetes Center, Dr. Abrahamson led the reorganization of the Adult Diabetes Section into multidisciplinary teams comprised of physicians, nurse practitioners, nurse educators, nutritionists, and exercise physiologists and spearheaded “pathways of care” for patients referred to Joslin (JoslinCare).
Dr. Abrahamson has co-authored guidelines for the pharmacological and perioperative management of patients with diabetes and management of hyperglycemic emergencies and authored more than 80 papers, review articles, and chapters related to diabetes. His research interests include the management of patients with diabetes and use of technology to improve diabetes care and outcomes. Dr. Abrahamson is board certified in endocrinology, diabetes and metabolism and is a fellow of the College of Physicians of South Africa. He has been cited regularly in Boston Magazine as one of Boston’s top doctors, and he has delivered numerous invited lectures nationally and internationally on the management of diabetes. In 2010, he was the recipient of the Samuel Eichold II Memorial Award for contributions to Diabetes from the American College of Physicians.